New mRNA Vaccine Offers Hope for Lyme Disease Prevention
Background Lyme disease, caused by the bacterium Borrelia burgdorferi, remains the most common vector-borne illness in the United States. With approximately 476,000 cases diagnosed annually, it poses a growing public…
Breakthrough in Nanoparticle-Based Drug Delivery: A New Hope for Lung Cancer and COPD Treatment
Lung cancer (LC) and chronic obstructive pulmonary disease (COPD) remain among the leading causes of mortality worldwide, driven by factors such as smoking-induced inflammation, oxidative stress, and tissue remodeling. Despite…